nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—CYP3A5—Clonidine—glaucoma	0.0517	0.172	CbGbCtD
Tacrolimus—CYP3A4—Pilocarpine—glaucoma	0.0413	0.137	CbGbCtD
Tacrolimus—ABCB1—Timolol—glaucoma	0.0396	0.132	CbGbCtD
Tacrolimus—ABCB1—Clonidine—glaucoma	0.0337	0.112	CbGbCtD
Tacrolimus—CYP3A4—Brinzolamide—glaucoma	0.0324	0.108	CbGbCtD
Tacrolimus—CYP3A4—Dorzolamide—glaucoma	0.0313	0.104	CbGbCtD
Tacrolimus—CYP3A4—Methazolamide—glaucoma	0.0279	0.0929	CbGbCtD
Tacrolimus—CYP3A4—Acetazolamide—glaucoma	0.0223	0.0742	CbGbCtD
Tacrolimus—CYP3A4—Clonidine—glaucoma	0.0202	0.0671	CbGbCtD
Tacrolimus—ABCA5—eye—glaucoma	0.00207	0.161	CbGeAlD
Tacrolimus—ABCA5—retina—glaucoma	0.00205	0.159	CbGeAlD
Tacrolimus—PPP3CA—retina—glaucoma	0.00139	0.108	CbGeAlD
Tacrolimus—PPP3CA—connective tissue—glaucoma	0.00135	0.105	CbGeAlD
Tacrolimus—MTOR—eye—glaucoma	0.00103	0.0803	CbGeAlD
Tacrolimus—MTOR—retina—glaucoma	0.00102	0.0796	CbGeAlD
Tacrolimus—MTOR—connective tissue—glaucoma	0.000996	0.0774	CbGeAlD
Tacrolimus—FKBP1A—eye—glaucoma	0.00093	0.0722	CbGeAlD
Tacrolimus—FKBP1A—retina—glaucoma	0.000921	0.0716	CbGeAlD
Tacrolimus—FKBP1A—connective tissue—glaucoma	0.000896	0.0696	CbGeAlD
Tacrolimus—ABCB1—retina—glaucoma	0.000213	0.0166	CbGeAlD
Tacrolimus—Loss of consciousness—Clonidine—glaucoma	0.000174	0.000343	CcSEcCtD
Tacrolimus—Feeling abnormal—Brinzolamide—glaucoma	0.000174	0.000342	CcSEcCtD
Tacrolimus—Mental disorder—Betaxolol—glaucoma	0.000174	0.000342	CcSEcCtD
Tacrolimus—Pain—Pilocarpine—glaucoma	0.000173	0.000341	CcSEcCtD
Tacrolimus—Constipation—Pilocarpine—glaucoma	0.000173	0.000341	CcSEcCtD
Tacrolimus—Cough—Clonidine—glaucoma	0.000173	0.00034	CcSEcCtD
Tacrolimus—Sweating—Timolol—glaucoma	0.000173	0.00034	CcSEcCtD
Tacrolimus—Dizziness—Apraclonidine—glaucoma	0.000173	0.00034	CcSEcCtD
Tacrolimus—Erythema—Betaxolol—glaucoma	0.000173	0.00034	CcSEcCtD
Tacrolimus—Malnutrition—Betaxolol—glaucoma	0.000173	0.00034	CcSEcCtD
Tacrolimus—Urticaria—Dorzolamide—glaucoma	0.00017	0.000335	CcSEcCtD
Tacrolimus—Epistaxis—Timolol—glaucoma	0.00017	0.000335	CcSEcCtD
Tacrolimus—Body temperature increased—Dorzolamide—glaucoma	0.000169	0.000333	CcSEcCtD
Tacrolimus—Abdominal pain—Dorzolamide—glaucoma	0.000169	0.000333	CcSEcCtD
Tacrolimus—Tension—Betaxolol—glaucoma	0.000169	0.000333	CcSEcCtD
Tacrolimus—Sinusitis—Timolol—glaucoma	0.000169	0.000333	CcSEcCtD
Tacrolimus—Dysgeusia—Betaxolol—glaucoma	0.000169	0.000332	CcSEcCtD
Tacrolimus—Arthralgia—Clonidine—glaucoma	0.000169	0.000332	CcSEcCtD
Tacrolimus—Chest pain—Clonidine—glaucoma	0.000169	0.000332	CcSEcCtD
Tacrolimus—Abdominal pain—Travoprost—glaucoma	0.000169	0.000332	CcSEcCtD
Tacrolimus—Agranulocytosis—Timolol—glaucoma	0.000168	0.000331	CcSEcCtD
Tacrolimus—Anxiety—Clonidine—glaucoma	0.000168	0.000331	CcSEcCtD
Tacrolimus—Asthenia—Acetazolamide—glaucoma	0.000168	0.00033	CcSEcCtD
Tacrolimus—Dizziness—Bimatoprost—glaucoma	0.000168	0.00033	CcSEcCtD
Tacrolimus—Nervousness—Betaxolol—glaucoma	0.000168	0.00033	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000168	0.00033	CcSEcCtD
Tacrolimus—Urticaria—Brinzolamide—glaucoma	0.000167	0.000329	CcSEcCtD
Tacrolimus—Feeling abnormal—Pilocarpine—glaucoma	0.000167	0.000328	CcSEcCtD
Tacrolimus—Discomfort—Clonidine—glaucoma	0.000167	0.000328	CcSEcCtD
Tacrolimus—Vomiting—Apraclonidine—glaucoma	0.000166	0.000327	CcSEcCtD
Tacrolimus—Muscle spasms—Betaxolol—glaucoma	0.000166	0.000326	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Pilocarpine—glaucoma	0.000166	0.000326	CcSEcCtD
Tacrolimus—Hypersensitivity—Brimonidine—glaucoma	0.000165	0.000325	CcSEcCtD
Tacrolimus—Dry mouth—Clonidine—glaucoma	0.000165	0.000325	CcSEcCtD
Tacrolimus—Bradycardia—Timolol—glaucoma	0.000165	0.000324	CcSEcCtD
Tacrolimus—Dermatitis—Apraclonidine—glaucoma	0.000165	0.000324	CcSEcCtD
Tacrolimus—Headache—Apraclonidine—glaucoma	0.000164	0.000322	CcSEcCtD
Tacrolimus—Confusional state—Clonidine—glaucoma	0.000163	0.000321	CcSEcCtD
Tacrolimus—Vision blurred—Betaxolol—glaucoma	0.000163	0.00032	CcSEcCtD
Tacrolimus—Rhinitis—Timolol—glaucoma	0.000162	0.000319	CcSEcCtD
Tacrolimus—Oedema—Clonidine—glaucoma	0.000162	0.000318	CcSEcCtD
Tacrolimus—Tremor—Betaxolol—glaucoma	0.000162	0.000318	CcSEcCtD
Tacrolimus—Hallucination—Timolol—glaucoma	0.000161	0.000317	CcSEcCtD
Tacrolimus—Asthenia—Brimonidine—glaucoma	0.000161	0.000317	CcSEcCtD
Tacrolimus—Infection—Clonidine—glaucoma	0.000161	0.000316	CcSEcCtD
Tacrolimus—Abdominal pain—Pilocarpine—glaucoma	0.00016	0.000315	CcSEcCtD
Tacrolimus—Body temperature increased—Pilocarpine—glaucoma	0.00016	0.000315	CcSEcCtD
Tacrolimus—Ill-defined disorder—Betaxolol—glaucoma	0.00016	0.000315	CcSEcCtD
Tacrolimus—Diarrhoea—Acetazolamide—glaucoma	0.00016	0.000315	CcSEcCtD
Tacrolimus—Rash—Bimatoprost—glaucoma	0.00016	0.000314	CcSEcCtD
Tacrolimus—Dermatitis—Bimatoprost—glaucoma	0.00016	0.000314	CcSEcCtD
Tacrolimus—Oedema peripheral—Timolol—glaucoma	0.000159	0.000314	CcSEcCtD
Tacrolimus—Anaemia—Betaxolol—glaucoma	0.000159	0.000314	CcSEcCtD
Tacrolimus—Shock—Clonidine—glaucoma	0.000159	0.000313	CcSEcCtD
Tacrolimus—Connective tissue disorder—Timolol—glaucoma	0.000159	0.000313	CcSEcCtD
Tacrolimus—Pruritus—Brimonidine—glaucoma	0.000159	0.000312	CcSEcCtD
Tacrolimus—Headache—Bimatoprost—glaucoma	0.000159	0.000312	CcSEcCtD
Tacrolimus—Nervous system disorder—Clonidine—glaucoma	0.000159	0.000312	CcSEcCtD
Tacrolimus—Thrombocytopenia—Clonidine—glaucoma	0.000158	0.000312	CcSEcCtD
Tacrolimus—Hypersensitivity—Dorzolamide—glaucoma	0.000158	0.000311	CcSEcCtD
Tacrolimus—Tachycardia—Clonidine—glaucoma	0.000158	0.000311	CcSEcCtD
Tacrolimus—Hypersensitivity—Travoprost—glaucoma	0.000157	0.000309	CcSEcCtD
Tacrolimus—Skin disorder—Clonidine—glaucoma	0.000157	0.000309	CcSEcCtD
Tacrolimus—Hyperhidrosis—Clonidine—glaucoma	0.000156	0.000308	CcSEcCtD
Tacrolimus—Visual impairment—Timolol—glaucoma	0.000156	0.000307	CcSEcCtD
Tacrolimus—Malaise—Betaxolol—glaucoma	0.000156	0.000306	CcSEcCtD
Tacrolimus—Nausea—Apraclonidine—glaucoma	0.000155	0.000306	CcSEcCtD
Tacrolimus—Hypersensitivity—Brinzolamide—glaucoma	0.000155	0.000306	CcSEcCtD
Tacrolimus—Vertigo—Betaxolol—glaucoma	0.000155	0.000305	CcSEcCtD
Tacrolimus—Syncope—Betaxolol—glaucoma	0.000155	0.000304	CcSEcCtD
Tacrolimus—Dizziness—Acetazolamide—glaucoma	0.000155	0.000304	CcSEcCtD
Tacrolimus—Anorexia—Clonidine—glaucoma	0.000154	0.000303	CcSEcCtD
Tacrolimus—Asthenia—Dorzolamide—glaucoma	0.000154	0.000303	CcSEcCtD
Tacrolimus—Asthenia—Travoprost—glaucoma	0.000153	0.000301	CcSEcCtD
Tacrolimus—Palpitations—Betaxolol—glaucoma	0.000152	0.0003	CcSEcCtD
Tacrolimus—Pruritus—Dorzolamide—glaucoma	0.000152	0.000298	CcSEcCtD
Tacrolimus—Loss of consciousness—Betaxolol—glaucoma	0.000152	0.000298	CcSEcCtD
Tacrolimus—Eye disorder—Timolol—glaucoma	0.000151	0.000298	CcSEcCtD
Tacrolimus—Asthenia—Brinzolamide—glaucoma	0.000151	0.000298	CcSEcCtD
Tacrolimus—Hypotension—Clonidine—glaucoma	0.000151	0.000297	CcSEcCtD
Tacrolimus—Pruritus—Travoprost—glaucoma	0.000151	0.000297	CcSEcCtD
Tacrolimus—Tinnitus—Timolol—glaucoma	0.000151	0.000297	CcSEcCtD
Tacrolimus—Cough—Betaxolol—glaucoma	0.000151	0.000296	CcSEcCtD
Tacrolimus—Nausea—Bimatoprost—glaucoma	0.000151	0.000296	CcSEcCtD
Tacrolimus—Cardiac disorder—Timolol—glaucoma	0.00015	0.000296	CcSEcCtD
Tacrolimus—Hypersensitivity—Pilocarpine—glaucoma	0.000149	0.000294	CcSEcCtD
Tacrolimus—Pruritus—Brinzolamide—glaucoma	0.000149	0.000293	CcSEcCtD
Tacrolimus—Vomiting—Acetazolamide—glaucoma	0.000149	0.000293	CcSEcCtD
Tacrolimus—Dizziness—Brimonidine—glaucoma	0.000148	0.000292	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Clonidine—glaucoma	0.000147	0.00029	CcSEcCtD
Tacrolimus—Angiopathy—Timolol—glaucoma	0.000147	0.000289	CcSEcCtD
Tacrolimus—Chest pain—Betaxolol—glaucoma	0.000147	0.000289	CcSEcCtD
Tacrolimus—Myalgia—Betaxolol—glaucoma	0.000147	0.000289	CcSEcCtD
Tacrolimus—Arthralgia—Betaxolol—glaucoma	0.000147	0.000289	CcSEcCtD
Tacrolimus—Diarrhoea—Dorzolamide—glaucoma	0.000147	0.000289	CcSEcCtD
Tacrolimus—Headache—Acetazolamide—glaucoma	0.000146	0.000288	CcSEcCtD
Tacrolimus—Anxiety—Betaxolol—glaucoma	0.000146	0.000288	CcSEcCtD
Tacrolimus—Insomnia—Clonidine—glaucoma	0.000146	0.000288	CcSEcCtD
Tacrolimus—Immune system disorder—Timolol—glaucoma	0.000146	0.000288	CcSEcCtD
Tacrolimus—Diarrhoea—Travoprost—glaucoma	0.000146	0.000287	CcSEcCtD
Tacrolimus—Mediastinal disorder—Timolol—glaucoma	0.000146	0.000287	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000146	0.000287	CcSEcCtD
Tacrolimus—Asthenia—Pilocarpine—glaucoma	0.000145	0.000286	CcSEcCtD
Tacrolimus—Paraesthesia—Clonidine—glaucoma	0.000145	0.000286	CcSEcCtD
Tacrolimus—Discomfort—Betaxolol—glaucoma	0.000145	0.000286	CcSEcCtD
Tacrolimus—Arrhythmia—Timolol—glaucoma	0.000145	0.000285	CcSEcCtD
Tacrolimus—Dyspnoea—Clonidine—glaucoma	0.000144	0.000284	CcSEcCtD
Tacrolimus—Diarrhoea—Brinzolamide—glaucoma	0.000144	0.000284	CcSEcCtD
Tacrolimus—Somnolence—Clonidine—glaucoma	0.000144	0.000283	CcSEcCtD
Tacrolimus—Dry mouth—Betaxolol—glaucoma	0.000144	0.000283	CcSEcCtD
Tacrolimus—Pruritus—Pilocarpine—glaucoma	0.000143	0.000282	CcSEcCtD
Tacrolimus—Alopecia—Timolol—glaucoma	0.000143	0.000282	CcSEcCtD
Tacrolimus—Confusional state—Betaxolol—glaucoma	0.000142	0.000279	CcSEcCtD
Tacrolimus—Mental disorder—Timolol—glaucoma	0.000142	0.000279	CcSEcCtD
Tacrolimus—Dizziness—Dorzolamide—glaucoma	0.000142	0.000279	CcSEcCtD
Tacrolimus—Rash—Brimonidine—glaucoma	0.000141	0.000278	CcSEcCtD
Tacrolimus—Dermatitis—Brimonidine—glaucoma	0.000141	0.000278	CcSEcCtD
Tacrolimus—Dizziness—Travoprost—glaucoma	0.000141	0.000278	CcSEcCtD
Tacrolimus—Erythema—Timolol—glaucoma	0.000141	0.000277	CcSEcCtD
Tacrolimus—Malnutrition—Timolol—glaucoma	0.000141	0.000277	CcSEcCtD
Tacrolimus—Oedema—Betaxolol—glaucoma	0.000141	0.000277	CcSEcCtD
Tacrolimus—Headache—Brimonidine—glaucoma	0.000141	0.000277	CcSEcCtD
Tacrolimus—Decreased appetite—Clonidine—glaucoma	0.000141	0.000277	CcSEcCtD
Tacrolimus—Infection—Betaxolol—glaucoma	0.00014	0.000275	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Clonidine—glaucoma	0.00014	0.000275	CcSEcCtD
Tacrolimus—Fatigue—Clonidine—glaucoma	0.000139	0.000274	CcSEcCtD
Tacrolimus—Dizziness—Brinzolamide—glaucoma	0.000139	0.000274	CcSEcCtD
Tacrolimus—Nausea—Acetazolamide—glaucoma	0.000139	0.000273	CcSEcCtD
Tacrolimus—Diarrhoea—Pilocarpine—glaucoma	0.000139	0.000273	CcSEcCtD
Tacrolimus—Shock—Betaxolol—glaucoma	0.000139	0.000273	CcSEcCtD
Tacrolimus—Tension—Timolol—glaucoma	0.000138	0.000272	CcSEcCtD
Tacrolimus—Pain—Clonidine—glaucoma	0.000138	0.000272	CcSEcCtD
Tacrolimus—Constipation—Clonidine—glaucoma	0.000138	0.000272	CcSEcCtD
Tacrolimus—Nervous system disorder—Betaxolol—glaucoma	0.000138	0.000272	CcSEcCtD
Tacrolimus—Dysgeusia—Timolol—glaucoma	0.000138	0.000272	CcSEcCtD
Tacrolimus—Thrombocytopenia—Betaxolol—glaucoma	0.000138	0.000271	CcSEcCtD
Tacrolimus—Tachycardia—Betaxolol—glaucoma	0.000137	0.00027	CcSEcCtD
Tacrolimus—Nervousness—Timolol—glaucoma	0.000137	0.000269	CcSEcCtD
Tacrolimus—Skin disorder—Betaxolol—glaucoma	0.000137	0.000269	CcSEcCtD
Tacrolimus—Vomiting—Dorzolamide—glaucoma	0.000136	0.000268	CcSEcCtD
Tacrolimus—Hyperhidrosis—Betaxolol—glaucoma	0.000136	0.000268	CcSEcCtD
Tacrolimus—Rash—Dorzolamide—glaucoma	0.000135	0.000266	CcSEcCtD
Tacrolimus—Dermatitis—Dorzolamide—glaucoma	0.000135	0.000266	CcSEcCtD
Tacrolimus—Rash—Travoprost—glaucoma	0.000135	0.000265	CcSEcCtD
Tacrolimus—Dermatitis—Travoprost—glaucoma	0.000134	0.000265	CcSEcCtD
Tacrolimus—Headache—Dorzolamide—glaucoma	0.000134	0.000264	CcSEcCtD
Tacrolimus—Anorexia—Betaxolol—glaucoma	0.000134	0.000264	CcSEcCtD
Tacrolimus—Vomiting—Brinzolamide—glaucoma	0.000134	0.000264	CcSEcCtD
Tacrolimus—Dizziness—Pilocarpine—glaucoma	0.000134	0.000264	CcSEcCtD
Tacrolimus—Headache—Travoprost—glaucoma	0.000134	0.000263	CcSEcCtD
Tacrolimus—Nausea—Brimonidine—glaucoma	0.000133	0.000262	CcSEcCtD
Tacrolimus—Feeling abnormal—Clonidine—glaucoma	0.000133	0.000262	CcSEcCtD
Tacrolimus—Rash—Brinzolamide—glaucoma	0.000133	0.000261	CcSEcCtD
Tacrolimus—Vision blurred—Timolol—glaucoma	0.000133	0.000261	CcSEcCtD
Tacrolimus—Dermatitis—Brinzolamide—glaucoma	0.000133	0.000261	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Clonidine—glaucoma	0.000132	0.00026	CcSEcCtD
Tacrolimus—Headache—Brinzolamide—glaucoma	0.000132	0.00026	CcSEcCtD
Tacrolimus—Hypotension—Betaxolol—glaucoma	0.000132	0.000259	CcSEcCtD
Tacrolimus—Vomiting—Pilocarpine—glaucoma	0.000129	0.000253	CcSEcCtD
Tacrolimus—Urticaria—Clonidine—glaucoma	0.000128	0.000253	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000128	0.000252	CcSEcCtD
Tacrolimus—Abdominal pain—Clonidine—glaucoma	0.000128	0.000252	CcSEcCtD
Tacrolimus—Body temperature increased—Clonidine—glaucoma	0.000128	0.000252	CcSEcCtD
Tacrolimus—Rash—Pilocarpine—glaucoma	0.000128	0.000251	CcSEcCtD
Tacrolimus—Dermatitis—Pilocarpine—glaucoma	0.000128	0.000251	CcSEcCtD
Tacrolimus—Insomnia—Betaxolol—glaucoma	0.000127	0.000251	CcSEcCtD
Tacrolimus—Nausea—Dorzolamide—glaucoma	0.000127	0.000251	CcSEcCtD
Tacrolimus—Headache—Pilocarpine—glaucoma	0.000127	0.00025	CcSEcCtD
Tacrolimus—Nausea—Travoprost—glaucoma	0.000127	0.000249	CcSEcCtD
Tacrolimus—Vertigo—Timolol—glaucoma	0.000127	0.000249	CcSEcCtD
Tacrolimus—Paraesthesia—Betaxolol—glaucoma	0.000126	0.000249	CcSEcCtD
Tacrolimus—Syncope—Timolol—glaucoma	0.000126	0.000249	CcSEcCtD
Tacrolimus—Dyspnoea—Betaxolol—glaucoma	0.000126	0.000247	CcSEcCtD
Tacrolimus—Nausea—Brinzolamide—glaucoma	0.000125	0.000246	CcSEcCtD
Tacrolimus—Palpitations—Timolol—glaucoma	0.000125	0.000245	CcSEcCtD
Tacrolimus—Dyspepsia—Betaxolol—glaucoma	0.000124	0.000244	CcSEcCtD
Tacrolimus—Loss of consciousness—Timolol—glaucoma	0.000124	0.000244	CcSEcCtD
Tacrolimus—Cough—Timolol—glaucoma	0.000123	0.000242	CcSEcCtD
Tacrolimus—Decreased appetite—Betaxolol—glaucoma	0.000122	0.000241	CcSEcCtD
Tacrolimus—Hypertension—Timolol—glaucoma	0.000122	0.000239	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Betaxolol—glaucoma	0.000122	0.000239	CcSEcCtD
Tacrolimus—Fatigue—Betaxolol—glaucoma	0.000121	0.000239	CcSEcCtD
Tacrolimus—Pain—Betaxolol—glaucoma	0.00012	0.000237	CcSEcCtD
Tacrolimus—Constipation—Betaxolol—glaucoma	0.00012	0.000237	CcSEcCtD
Tacrolimus—Nausea—Pilocarpine—glaucoma	0.00012	0.000237	CcSEcCtD
Tacrolimus—Arthralgia—Timolol—glaucoma	0.00012	0.000236	CcSEcCtD
Tacrolimus—Myalgia—Timolol—glaucoma	0.00012	0.000236	CcSEcCtD
Tacrolimus—Chest pain—Timolol—glaucoma	0.00012	0.000236	CcSEcCtD
Tacrolimus—Anxiety—Timolol—glaucoma	0.00012	0.000235	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000119	0.000235	CcSEcCtD
Tacrolimus—Hypersensitivity—Clonidine—glaucoma	0.000119	0.000234	CcSEcCtD
Tacrolimus—MTOR—Signaling by SCF-KIT—MMP9—glaucoma	0.000119	0.000666	CbGpPWpGaD
Tacrolimus—Discomfort—Timolol—glaucoma	0.000119	0.000233	CcSEcCtD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000118	0.00066	CbGpPWpGaD
Tacrolimus—Dry mouth—Timolol—glaucoma	0.000117	0.000231	CcSEcCtD
Tacrolimus—CYP3A5—Biological oxidations—GSTM1—glaucoma	0.000117	0.000655	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TXNIP—glaucoma	0.000116	0.000651	CbGpPWpGaD
Tacrolimus—Asthenia—Clonidine—glaucoma	0.000116	0.000228	CcSEcCtD
Tacrolimus—Feeling abnormal—Betaxolol—glaucoma	0.000116	0.000228	CcSEcCtD
Tacrolimus—Confusional state—Timolol—glaucoma	0.000116	0.000228	CcSEcCtD
Tacrolimus—MTOR—Downstream signal transduction—CDKN1B—glaucoma	0.000116	0.000647	CbGpPWpGaD
Tacrolimus—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	0.000116	0.000646	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—EDN1—glaucoma	0.000115	0.000645	CbGpPWpGaD
Tacrolimus—Oedema—Timolol—glaucoma	0.000115	0.000226	CcSEcCtD
Tacrolimus—Anaphylactic shock—Timolol—glaucoma	0.000115	0.000226	CcSEcCtD
Tacrolimus—MTOR—Signaling by FGFR—CDKN1B—glaucoma	0.000115	0.000644	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—CDKN1B—glaucoma	0.000114	0.00064	CbGpPWpGaD
Tacrolimus—Pruritus—Clonidine—glaucoma	0.000114	0.000225	CcSEcCtD
Tacrolimus—Infection—Timolol—glaucoma	0.000114	0.000225	CcSEcCtD
Tacrolimus—MTOR—Immune System—TBK1—glaucoma	0.000114	0.000638	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—CDKN1B—glaucoma	0.000114	0.000637	CbGpPWpGaD
Tacrolimus—Shock—Timolol—glaucoma	0.000113	0.000223	CcSEcCtD
Tacrolimus—Nervous system disorder—Timolol—glaucoma	0.000113	0.000222	CcSEcCtD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000113	0.00063	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—glaucoma	0.000112	0.000628	CbGpPWpGaD
Tacrolimus—Urticaria—Betaxolol—glaucoma	0.000112	0.00022	CcSEcCtD
Tacrolimus—Skin disorder—Timolol—glaucoma	0.000112	0.00022	CcSEcCtD
Tacrolimus—Body temperature increased—Betaxolol—glaucoma	0.000111	0.000219	CcSEcCtD
Tacrolimus—Hyperhidrosis—Timolol—glaucoma	0.000111	0.000219	CcSEcCtD
Tacrolimus—ALB—Metabolism—NARFL—glaucoma	0.000111	0.000621	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CA5A—glaucoma	0.000111	0.000621	CbGpPWpGaD
Tacrolimus—Diarrhoea—Clonidine—glaucoma	0.000111	0.000218	CcSEcCtD
Tacrolimus—Anorexia—Timolol—glaucoma	0.00011	0.000216	CcSEcCtD
Tacrolimus—Hypotension—Timolol—glaucoma	0.000107	0.000212	CcSEcCtD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—CDKN1B—glaucoma	0.000107	0.0006	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—CDKN1B—glaucoma	0.000107	0.0006	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—CDKN1B—glaucoma	0.000107	0.0006	CbGpPWpGaD
Tacrolimus—Dizziness—Clonidine—glaucoma	0.000107	0.00021	CcSEcCtD
Tacrolimus—MTOR—Signaling by EGFR—CDKN1B—glaucoma	0.000106	0.000594	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—CDKN1B—glaucoma	0.000105	0.000589	CbGpPWpGaD
Tacrolimus—Musculoskeletal discomfort—Timolol—glaucoma	0.000105	0.000206	CcSEcCtD
Tacrolimus—MTOR—Signaling by NGF—BAD—glaucoma	0.000105	0.000586	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—CDKN1B—glaucoma	0.000105	0.000586	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL1A—glaucoma	0.000105	0.000586	CbGpPWpGaD
Tacrolimus—Insomnia—Timolol—glaucoma	0.000104	0.000205	CcSEcCtD
Tacrolimus—Hypersensitivity—Betaxolol—glaucoma	0.000104	0.000204	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—SMO—glaucoma	0.000103	0.000578	CbGpPWpGaD
Tacrolimus—Paraesthesia—Timolol—glaucoma	0.000103	0.000203	CcSEcCtD
Tacrolimus—MTOR—Immune System—C1QB—glaucoma	0.000103	0.000577	CbGpPWpGaD
Tacrolimus—Vomiting—Clonidine—glaucoma	0.000103	0.000202	CcSEcCtD
Tacrolimus—Dyspnoea—Timolol—glaucoma	0.000103	0.000202	CcSEcCtD
Tacrolimus—FKBP1A—Signaling Pathways—HDAC9—glaucoma	0.000102	0.000573	CbGpPWpGaD
Tacrolimus—Somnolence—Timolol—glaucoma	0.000102	0.000201	CcSEcCtD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—TP53—glaucoma	0.000102	0.000572	CbGpPWpGaD
Tacrolimus—Rash—Clonidine—glaucoma	0.000102	0.000201	CcSEcCtD
Tacrolimus—Dermatitis—Clonidine—glaucoma	0.000102	0.0002	CcSEcCtD
Tacrolimus—ALB—Vitamin B12 Metabolism—TNF—glaucoma	0.000102	0.000568	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—CDKN2B—glaucoma	0.000101	0.000567	CbGpPWpGaD
Tacrolimus—Headache—Clonidine—glaucoma	0.000101	0.000199	CcSEcCtD
Tacrolimus—Dyspepsia—Timolol—glaucoma	0.000101	0.000199	CcSEcCtD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000101	0.000566	CbGpPWpGaD
Tacrolimus—Asthenia—Betaxolol—glaucoma	0.000101	0.000199	CcSEcCtD
Tacrolimus—PPP3CA—Signaling by GPCR—C3—glaucoma	0.000101	0.000564	CbGpPWpGaD
Tacrolimus—Decreased appetite—Timolol—glaucoma	0.0001	0.000197	CcSEcCtD
Tacrolimus—Pruritus—Betaxolol—glaucoma	9.96e-05	0.000196	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Timolol—glaucoma	9.93e-05	0.000195	CcSEcCtD
Tacrolimus—MTOR—Signaling Pathways—OPN4—glaucoma	9.92e-05	0.000555	CbGpPWpGaD
Tacrolimus—Fatigue—Timolol—glaucoma	9.92e-05	0.000195	CcSEcCtD
Tacrolimus—MTOR—B Cell Activation—CDKN1B—glaucoma	9.91e-05	0.000555	CbGpPWpGaD
Tacrolimus—Pain—Timolol—glaucoma	9.84e-05	0.000194	CcSEcCtD
Tacrolimus—ABCB1—Metabolism—NARFL—glaucoma	9.72e-05	0.000544	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CA5A—glaucoma	9.72e-05	0.000544	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—PTGS2—glaucoma	9.72e-05	0.000544	CbGpPWpGaD
Tacrolimus—Diarrhoea—Betaxolol—glaucoma	9.63e-05	0.00019	CcSEcCtD
Tacrolimus—Nausea—Clonidine—glaucoma	9.61e-05	0.000189	CcSEcCtD
Tacrolimus—PPP3CA—Innate Immune System—CDKN1B—glaucoma	9.54e-05	0.000534	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	9.49e-05	0.000531	CbGpPWpGaD
Tacrolimus—Feeling abnormal—Timolol—glaucoma	9.48e-05	0.000187	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—NTRK2—glaucoma	9.45e-05	0.000529	CbGpPWpGaD
Tacrolimus—Gastrointestinal pain—Timolol—glaucoma	9.41e-05	0.000185	CcSEcCtD
Tacrolimus—Dizziness—Betaxolol—glaucoma	9.31e-05	0.000183	CcSEcCtD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	9.3e-05	0.00052	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HEYL—glaucoma	9.22e-05	0.000516	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—SOD1—glaucoma	9.2e-05	0.000515	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—C3—glaucoma	9.2e-05	0.000515	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TXN—glaucoma	9.19e-05	0.000514	CbGpPWpGaD
Tacrolimus—Urticaria—Timolol—glaucoma	9.14e-05	0.00018	CcSEcCtD
Tacrolimus—Body temperature increased—Timolol—glaucoma	9.09e-05	0.000179	CcSEcCtD
Tacrolimus—Abdominal pain—Timolol—glaucoma	9.09e-05	0.000179	CcSEcCtD
Tacrolimus—ALB—Transmembrane transport of small molecules—SLC6A13—glaucoma	9.08e-05	0.000508	CbGpPWpGaD
Tacrolimus—Vomiting—Betaxolol—glaucoma	8.95e-05	0.000176	CcSEcCtD
Tacrolimus—MTOR—Signaling Pathways—PTGFR—glaucoma	8.93e-05	0.0005	CbGpPWpGaD
Tacrolimus—Rash—Betaxolol—glaucoma	8.88e-05	0.000175	CcSEcCtD
Tacrolimus—Dermatitis—Betaxolol—glaucoma	8.87e-05	0.000175	CcSEcCtD
Tacrolimus—Headache—Betaxolol—glaucoma	8.82e-05	0.000174	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—BCL2L1—glaucoma	8.81e-05	0.000493	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—CDKN2A—glaucoma	8.79e-05	0.000492	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CA1—glaucoma	8.71e-05	0.000487	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	8.57e-05	0.00048	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—GSTT1—glaucoma	8.55e-05	0.000478	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	8.51e-05	0.000476	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—MTHFR—glaucoma	8.5e-05	0.000475	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Timolol—glaucoma	8.47e-05	0.000167	CcSEcCtD
Tacrolimus—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	8.44e-05	0.000473	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CTSA—glaucoma	8.43e-05	0.000472	CbGpPWpGaD
Tacrolimus—Nausea—Betaxolol—glaucoma	8.36e-05	0.000165	CcSEcCtD
Tacrolimus—ALB—Platelet degranulation—VEGFA—glaucoma	8.26e-05	0.000462	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—TNF—glaucoma	8.26e-05	0.000462	CbGpPWpGaD
Tacrolimus—Asthenia—Timolol—glaucoma	8.25e-05	0.000162	CcSEcCtD
Tacrolimus—MTOR—Disease—HDAC9—glaucoma	8.22e-05	0.00046	CbGpPWpGaD
Tacrolimus—Pruritus—Timolol—glaucoma	8.14e-05	0.00016	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—NGFR—glaucoma	8.11e-05	0.000454	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SMO—glaucoma	8.01e-05	0.000448	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—BAD—glaucoma	7.98e-05	0.000447	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CA2—glaucoma	7.96e-05	0.000446	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.96e-05	0.000445	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—APOE—glaucoma	7.91e-05	0.000443	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	7.87e-05	0.000441	CbGpPWpGaD
Tacrolimus—Diarrhoea—Timolol—glaucoma	7.87e-05	0.000155	CcSEcCtD
Tacrolimus—FKBP1A—Disease—CDKN2B—glaucoma	7.86e-05	0.00044	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—CAV1—glaucoma	7.84e-05	0.000439	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—CDKN1B—glaucoma	7.78e-05	0.000435	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—NTRK1—glaucoma	7.7e-05	0.000431	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—TP53—glaucoma	7.64e-05	0.000428	CbGpPWpGaD
Tacrolimus—Dizziness—Timolol—glaucoma	7.61e-05	0.00015	CcSEcCtD
Tacrolimus—PPP3CA—Disease—BAD—glaucoma	7.37e-05	0.000412	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NTRK2—glaucoma	7.33e-05	0.00041	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—VEGFA—glaucoma	7.31e-05	0.000409	CbGpPWpGaD
Tacrolimus—Vomiting—Timolol—glaucoma	7.31e-05	0.000144	CcSEcCtD
Tacrolimus—MTOR—Signaling by NGF—CDKN1B—glaucoma	7.3e-05	0.000408	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	7.29e-05	0.000408	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—TP53—glaucoma	7.28e-05	0.000408	CbGpPWpGaD
Tacrolimus—Rash—Timolol—glaucoma	7.25e-05	0.000143	CcSEcCtD
Tacrolimus—Dermatitis—Timolol—glaucoma	7.25e-05	0.000143	CcSEcCtD
Tacrolimus—Headache—Timolol—glaucoma	7.21e-05	0.000142	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—CDKN2B—glaucoma	7.1e-05	0.000397	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RPTOR—glaucoma	6.99e-05	0.000391	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—C3—glaucoma	6.89e-05	0.000386	CbGpPWpGaD
Tacrolimus—Nausea—Timolol—glaucoma	6.83e-05	0.000134	CcSEcCtD
Tacrolimus—CYP3A4—Biological oxidations—CYP1B1—glaucoma	6.81e-05	0.000381	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—EDN1—glaucoma	6.81e-05	0.000381	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NCK2—glaucoma	6.77e-05	0.000379	CbGpPWpGaD
Tacrolimus—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	6.72e-05	0.000376	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	6.65e-05	0.000372	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—C3—glaucoma	6.62e-05	0.00037	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—BCL2L1—glaucoma	6.59e-05	0.000369	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—MTHFR—glaucoma	6.59e-05	0.000369	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—TNF—glaucoma	6.56e-05	0.000367	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—VEGFA—glaucoma	6.47e-05	0.000362	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	6.4e-05	0.000358	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CA1—glaucoma	6.29e-05	0.000352	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NGFR—glaucoma	6.28e-05	0.000352	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—TNF—glaucoma	6.27e-05	0.000351	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TGFB2—glaucoma	6.26e-05	0.00035	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—NGF—glaucoma	6.26e-05	0.00035	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	6.23e-05	0.000349	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—APOE—glaucoma	6.13e-05	0.000343	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CTSA—glaucoma	6.09e-05	0.000341	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CAV1—glaucoma	6.08e-05	0.00034	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CA5A—glaucoma	5.99e-05	0.000335	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NARFL—glaucoma	5.99e-05	0.000335	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—BAD—glaucoma	5.98e-05	0.000334	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NTRK1—glaucoma	5.97e-05	0.000334	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—C3—glaucoma	5.95e-05	0.000333	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—NOS3—glaucoma	5.93e-05	0.000332	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.82e-05	0.000326	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HDAC9—glaucoma	5.76e-05	0.000322	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CA2—glaucoma	5.76e-05	0.000322	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—BAD—glaucoma	5.74e-05	0.000321	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—BAD—glaucoma	5.71e-05	0.00032	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—TXN—glaucoma	5.61e-05	0.000314	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CDKN1B—glaucoma	5.56e-05	0.000311	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—APOE—glaucoma	5.54e-05	0.00031	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CDKN2B—glaucoma	5.5e-05	0.000308	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CAV1—glaucoma	5.49e-05	0.000307	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—GSTM1—glaucoma	5.44e-05	0.000305	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CA1—glaucoma	5.42e-05	0.000303	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—PTGS2—glaucoma	5.42e-05	0.000303	CbGpPWpGaD
Tacrolimus—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	5.37e-05	0.000301	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—EDN1—glaucoma	5.28e-05	0.000296	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CTSA—glaucoma	5.25e-05	0.000294	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—FN1—glaucoma	5.22e-05	0.000292	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—BAD—glaucoma	5.16e-05	0.000289	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—CDKN1B—glaucoma	5.13e-05	0.000287	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CA2—glaucoma	4.96e-05	0.000277	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—TP53—glaucoma	4.89e-05	0.000274	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NGF—glaucoma	4.85e-05	0.000272	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.84e-05	0.000271	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.84e-05	0.000271	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CA1—glaucoma	4.75e-05	0.000266	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—SOD1—glaucoma	4.74e-05	0.000265	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—C3—glaucoma	4.61e-05	0.000258	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CTSA—glaucoma	4.6e-05	0.000257	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—NOS3—glaucoma	4.59e-05	0.000257	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	4.58e-05	0.000256	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1A—glaucoma	4.57e-05	0.000256	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SMO—glaucoma	4.5e-05	0.000252	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CDKN2B—glaucoma	4.42e-05	0.000247	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GSTT1—glaucoma	4.35e-05	0.000243	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CA2—glaucoma	4.34e-05	0.000243	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	4.34e-05	0.000243	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—APOE—glaucoma	4.29e-05	0.00024	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CAV1—glaucoma	4.25e-05	0.000238	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PTGS2—glaucoma	4.2e-05	0.000235	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CDKN1B—glaucoma	4.16e-05	0.000233	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—NOS3—glaucoma	4.15e-05	0.000232	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NTRK2—glaucoma	4.12e-05	0.000231	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—TXN—glaucoma	4.06e-05	0.000227	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—FN1—glaucoma	4.05e-05	0.000227	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—C3—glaucoma	4.01e-05	0.000225	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—BAD—glaucoma	4e-05	0.000224	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CDKN1B—glaucoma	4e-05	0.000224	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CDKN1B—glaucoma	3.98e-05	0.000223	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—BCL2L1—glaucoma	3.84e-05	0.000215	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MTHFR—glaucoma	3.7e-05	0.000207	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	3.67e-05	0.000205	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—MMP1—glaucoma	3.62e-05	0.000202	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.61e-05	0.000202	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CDKN1B—glaucoma	3.59e-05	0.000201	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NGFR—glaucoma	3.53e-05	0.000198	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—TXN—glaucoma	3.49e-05	0.000195	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—BAD—glaucoma	3.48e-05	0.000195	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—CAV1—glaucoma	3.47e-05	0.000194	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ABCA1—glaucoma	3.47e-05	0.000194	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP1B1—glaucoma	3.47e-05	0.000194	CbGpPWpGaD
Tacrolimus—MTOR—Disease—APOE—glaucoma	3.45e-05	0.000193	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CAV1—glaucoma	3.42e-05	0.000191	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NTRK1—glaucoma	3.36e-05	0.000188	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MMP9—glaucoma	3.33e-05	0.000186	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—FN1—glaucoma	3.3e-05	0.000185	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NOS3—glaucoma	3.22e-05	0.00018	CbGpPWpGaD
Tacrolimus—MTOR—Disease—BAD—glaucoma	3.21e-05	0.00018	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.19e-05	0.000178	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.16e-05	0.000177	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTT1—glaucoma	3.14e-05	0.000176	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CDKN2B—glaucoma	3.09e-05	0.000173	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.09e-05	0.000173	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TXN—glaucoma	3.06e-05	0.000171	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—VEGFA—glaucoma	2.99e-05	0.000167	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—EDN1—glaucoma	2.97e-05	0.000166	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CA1—glaucoma	2.93e-05	0.000164	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CTSA—glaucoma	2.83e-05	0.000159	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CDKN1B—glaucoma	2.79e-05	0.000156	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GSTM1—glaucoma	2.77e-05	0.000155	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NGF—glaucoma	2.73e-05	0.000153	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.73e-05	0.000153	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTT1—glaucoma	2.71e-05	0.000152	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CA2—glaucoma	2.68e-05	0.00015	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—NOS3—glaucoma	2.62e-05	0.000147	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—C3—glaucoma	2.59e-05	0.000145	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NOS3—glaucoma	2.58e-05	0.000145	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MMP9—glaucoma	2.58e-05	0.000144	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ABCA1—glaucoma	2.51e-05	0.00014	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP1B1—glaucoma	2.51e-05	0.00014	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—MTHFR—glaucoma	2.45e-05	0.000137	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CDKN1B—glaucoma	2.42e-05	0.000136	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—APOE—glaucoma	2.42e-05	0.000135	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CAV1—glaucoma	2.39e-05	0.000134	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTT1—glaucoma	2.37e-05	0.000133	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PTGS2—glaucoma	2.36e-05	0.000132	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—VEGFA—glaucoma	2.32e-05	0.00013	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—APOE—glaucoma	2.28e-05	0.000128	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FN1—glaucoma	2.28e-05	0.000127	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CAV1—glaucoma	2.26e-05	0.000126	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TP53—glaucoma	2.26e-05	0.000126	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—BAD—glaucoma	2.25e-05	0.000126	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CDKN1B—glaucoma	2.24e-05	0.000125	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.18e-05	0.000122	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP1B1—glaucoma	2.16e-05	0.000121	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ABCA1—glaucoma	2.16e-05	0.000121	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTM1—glaucoma	2e-05	0.000112	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ABCA1—glaucoma	1.89e-05	0.000106	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP1B1—glaucoma	1.89e-05	0.000106	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—VEGFA—glaucoma	1.89e-05	0.000106	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TXN—glaucoma	1.89e-05	0.000106	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NOS3—glaucoma	1.81e-05	0.000101	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MTHFR—glaucoma	1.77e-05	9.91e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TP53—glaucoma	1.75e-05	9.8e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTM1—glaucoma	1.72e-05	9.65e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—NOS3—glaucoma	1.71e-05	9.56e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—APOE—glaucoma	1.65e-05	9.22e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CAV1—glaucoma	1.63e-05	9.14e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CDKN1B—glaucoma	1.57e-05	8.77e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTGS2—glaucoma	1.56e-05	8.74e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MTHFR—glaucoma	1.52e-05	8.53e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTM1—glaucoma	1.51e-05	8.46e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTT1—glaucoma	1.46e-05	8.18e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MMP9—glaucoma	1.45e-05	8.12e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TP53—glaucoma	1.43e-05	7.99e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—APOE—glaucoma	1.42e-05	7.94e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CAV1—glaucoma	1.41e-05	7.87e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MTHFR—glaucoma	1.34e-05	7.48e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—VEGFA—glaucoma	1.3e-05	7.3e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOE—glaucoma	1.24e-05	6.96e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—NOS3—glaucoma	1.23e-05	6.91e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CAV1—glaucoma	1.23e-05	6.89e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ABCA1—glaucoma	1.16e-05	6.52e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP1B1—glaucoma	1.16e-05	6.52e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTGS2—glaucoma	1.13e-05	6.32e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NOS3—glaucoma	1.06e-05	5.95e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TP53—glaucoma	9.85e-06	5.51e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTGS2—glaucoma	9.72e-06	5.44e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NOS3—glaucoma	9.32e-06	5.21e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTM1—glaucoma	9.31e-06	5.21e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTGS2—glaucoma	8.52e-06	4.77e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MTHFR—glaucoma	8.23e-06	4.61e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOE—glaucoma	7.66e-06	4.29e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CAV1—glaucoma	7.59e-06	4.25e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NOS3—glaucoma	5.74e-06	3.21e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTGS2—glaucoma	5.25e-06	2.94e-05	CbGpPWpGaD
